An Evaluation of Safety and Efficacy of Escalating Doses of AMD3100 to Mobilize CD34+ Cells in Healthy Volunteers
Clinical trial NCT00322127 · COMPLETED
Trial details
- NCT number
- NCT00322127
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-14
- Primary completion
- 2015-01-23
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.